27
Participants
Start Date
August 31, 2008
Primary Completion Date
November 30, 2008
Study Completion Date
November 30, 2008
AZD3199
"Low dose~Dry powder for inhalation, o.d., 1+12 days"
Placebo
AZD3199
"intermediate dose~Dry powder for inhalation, o.d., 1+12 days"
AZD3199
"high dose~Dry powder for inhalation, o.d., 1+12 days"
Research Site, Lund
Lead Sponsor
AstraZeneca
INDUSTRY